Merck applies for approval of the first pill against Coronervirus

The American pharmaceutical company Merck said it has demanded that the emergency use of its pill be approved to treat coronary patients. The request was submitted Monday to the US Food and Bars Administration. If approved, Molnupiravir would become the first antiviral oral pills against the Coronobrus. It would help manage [...]
The American pharmaceutical company Merck said it has demanded that the emergency use of its pill be approved to treat coronary patients.
The request was submitted Monday to the US Food and Bars Administration.
If approved, Molnupiravir would become the first antiviral oral pills against the Coronobrus.
She would help with clinical management because she could be taken home.
According to the evidence, Molnupiravir treatment can halve the chances of death or hospitalize those most endangered by coronary infection, says Merck.
The pill is designed to trigger the errors of the virus's genetic code, which then prevent its spread into the body.
Evidence has suggested that Molnupiravir should be taken shortly after symptoms from the Coronobrus appear to have an effect.
Anthony Fauci, chief medical adviser to the American president, Joe Biden, has said that the results of the evidence are excellent <x0... good news”, but has called for caution until the American Food and Bars Administration examines the data.











